Article
Neurosciences
Nycole Maza, Dandan Wang, Cody Kowalski, Hannah M. Stoveken, Maria Dao, Omar K. Sial, Andrew C. Giles, Brock Grill, Kirill A. Martemyanov
Summary: Repeated exposure to opioids leads to the development of tolerance, limiting their analgesic effects and increasing the risk of abuse and overdose. This study identified Ptchd1 as a gene involved in regulating opioid tolerance through its effects on receptor trafficking and desensitization. The findings suggest an evolutionarily conserved role for Ptchd1 in protecting against opioid overstimulation.
NATURE NEUROSCIENCE
(2022)
Article
Chemistry, Medicinal
Madeline R. Hennessy, Anna M. Gutridge, Alexander R. French, Elizabeth S. Rhoda, Yazan J. Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M. van Rijn, Andrew P. Riley
Summary: Akuammine and pseudoakuammigine are indole alkaloids derived from the seeds of the akuamma tree. They act as weak agonists of the mu opioid receptor and show minimal effects in animal models of antinociception. By synthesizing 22 semisynthetic derivatives and evaluating their activity at the mu opioid receptor and kappa opioid receptor, we identified derivatives with improved potency at the mu opioid receptor.
JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Pharmacology & Pharmacy
Marc Lopez-Cano, Joan Font, Ester Aso, Kristoffer Sahlholm, Gisela Cabre, Jesus Giraldo, Yves De Koninck, Jordi Hernando, Amadeu Llebaria, Victor Fernandez-Duenas, Francisco Ciruela
Summary: Photopharmacology offers a promising approach to improve the benefit/risk profiles of opioid-based drugs. This study successfully developed a morphine photo-derivative that can be activated by light, providing effective analgesia without the occurrence of tolerance or associated opioid-related side effects.
BRITISH JOURNAL OF PHARMACOLOGY
(2023)
Article
Pharmacology & Pharmacy
Licet Caridad Mena-Valdes, Yisel Blanco-Hernandez, Josue Vidal Espinosa-Juarez, Francisco Javier Lopez-Munoz
Summary: The study demonstrated that in a neuropathic pain model, haloperidol enhanced the analgesic effect of morphine, delayed the development of morphine tolerance, and did not show significant adverse effects.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2021)
Review
Chemistry, Medicinal
Alok K. Paul, Craig M. Smith, Mohammed Rahmatullah, Veeranoot Nissapatorn, Polrat Wilairatana, Mariana Spetea, Nuri Gueven, Nikolas Dietis
Summary: Opioids are commonly used for pain management but have numerous adverse effects, particularly in older adults. Understanding the mechanisms of opioid-induced adverse reactions can aid in improving pain management strategies.
Article
Biochemistry & Molecular Biology
Yusuke Mizobuchi, Kanako Miyano, Sei Manabe, Eiko Uezono, Akane Komatsu, Yui Kuroda, Miki Nonaka, Yoshikazu Matsuoka, Tetsufumi Sato, Yasuhito Uezono, Hiroshi Morimatsu
Summary: This study investigated the effects of ketamine on opioid tolerance and its potential mechanisms. The results showed that ketamine improved acute desensitization and enhanced beta-arrestin recruitment elicited by fentanyl but not by morphine. These effects may involve modulation of GRK-mediated pathways.
Article
Pharmacology & Pharmacy
Sweta Adhikary, Omar Koita, Joseph J. Lebowitz, William T. Birdsong, John T. Williams
Summary: This study suggests that chronic opioid treatment alters kinase regulation of nonopioid GPCRs, highlighting the importance of sustained opioid receptor signaling in initiating adaptive processes downstream.
MOLECULAR PHARMACOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Shivani Batra, Shagufta Jahan, Anam Ashraf, Bandar Alharby, Talha Jawaid, Asimul Islam, Imtaiyaz Hassan
Summary: Cyclin-dependent kinase 5 (CDK5) is a serine/threonine-directed kinase primarily found in the brain that plays a crucial role in the development of the central nervous system. Recent research has shown that CDK5 is activated by specific cyclins, which regulate its expression and activity. This review examines the role of CDK5 in neurons, synaptic plasticity, DNA damage repair, and the cell cycle, highlighting its therapeutic potential as a target for neurodegenerative diseases. The structural features of CDK5 and its binding with designed inhibitors are also discussed, providing insights for the development of attractive strategies in therapeutic targeting.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
(2023)
Article
Neurosciences
Li Lin, Xiaodong Liu, Xuejun Cheng, Yujing Li, Marla Gearing, Allan Levey, Xiaoli Huang, Ying Li, Peng Jin, Xuekun Li
Summary: In this study, the altered expression and misregulation of miR-650 in Alzheimer's disease (AD) brains were observed. Bioinformatic analysis predicted that miR-650 targets three AD-associated genes, and experimental confirmation showed that miR-650 significantly reduces their expression levels in vitro. Overexpression of miR-650 was shown to alter CDK5 levels and ameliorate AD pathologies in transgenic mice. These findings suggest that miR-650 influences AD pathogenesis through regulation of CDK5.
MOLECULAR NEUROBIOLOGY
(2023)
Review
Medicine, Research & Experimental
Jie Zhou, Ruijie Ma, Ying Jin, Junfan Fang, Junying Du, Xiaomei Shao, Yi Liang, Jianqiao Fang
Summary: Prolonged use of opioids can lead to tolerance, addiction, and abuse. Understanding the mechanisms of opioid tolerance can help in developing new therapeutic approaches.
EXPERIMENTAL AND THERAPEUTIC MEDICINE
(2021)
Article
Pharmacology & Pharmacy
Kayla Johnson, Alexis Doucette, Alexis Edwards, Aleeya Verdi, Ryan McFarland, Shelby Hulke, Amanda Fowler, Val J. Watts, Amanda H. Klein
Summary: This study found that reducing the activity or expression of adenylyl cyclase 1 can attenuate morphine tolerance and hypersensitivity, as well as provide relief for inflammatory pain.
FRONTIERS IN PHARMACOLOGY
(2022)
Editorial Material
Chemistry, Medicinal
Mark Klein
Summary: Cyclin-dependent kinases (CDKs) have important roles in normal cells and can be targeted for cancer therapy. CDK4 inhibitors have been approved for advanced breast cancer treatment. However, the development of selective inhibitors for individual CDKs is challenging due to the highly conserved ATP-binding site.
Article
Microbiology
Juri Kim, Eun-Ah Park, Mee Young Shin, Soon-Jung Park
Summary: This study investigated the functional roles of Giardia lamblia CDKs (GlCDKs) and their cognate cyclins. Using morpholino-mediated knockdown and coimmunoprecipitation, the functions of GlCDK1 and GlCDK2 were distinguished. GlCDK1 with Glcyclin 3977 plays a crucial role in flagellum formation and cell cycle control of G. lamblia, while GlCDK2 with Glcyclin 22394/6584 is involved in cell cycle control.
MICROBIOLOGY SPECTRUM
(2023)
Article
Pharmacology & Pharmacy
Zachary W. Reichenbach, Kelly DiMattio, Suren Rajakaruna, David Ambrose, William D. Cornwell, Ronald J. Tallarida, Thomas Rogers, Lee-Yuan Liu-Chen, Ronald F. Tuma, Sara Jane Ward
Summary: Non-selective cannabinoid (CB) agonists can enhance the analgesic effects of morphine but inhibit its antinociceptive tolerance. Activation of CB2 receptors can reverse allodynia and hyperalgesia in chronic pain models, and co-administration of CB2 receptor selective agonists with morphine can synergistically enhance the effects. However, the interactions between CB2 receptor selective agonist O-1966 and morphine depend on the order of administration.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Pawel Lukasik, Michal Zaluski, Izabela Gutowska
Summary: Cyclin-dependent kinases are crucial in various cellular processes and their dysregulation can lead to diseases, making them potential drug targets.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Multidisciplinary Sciences
Guo-Qiang Wang, Cheng Cen, Chong Li, Shuai Cao, Ning Wang, Zheng Zhou, Xue-Mei Liu, Yu Xu, Na-Xi Tian, Ying Zhang, Jun Wang, Li-Ping Wang, Yun Wang
NATURE COMMUNICATIONS
(2015)
Article
Neurosciences
Ming Huang, Gen Cheng, Han Tan, Rui Qin, Yimin Zou, Yun Wang, Ying Zhang
EXPERIMENTAL NEUROLOGY
(2017)
Article
Neurosciences
Ying Zhang, Ping Su, Ping Liang, Tao Liu, Xu Liu, Xin-Ying Liu, Bo Zhang, Tao Han, Yan-Bing Zhu, Dong-Min Yin, Junfa Li, Zhuan Zhou, Ke-Wei Wang, Yun Wang
JOURNAL OF NEUROSCIENCE
(2010)
Article
Neurosciences
Bao-Ming Xing, Yan-Rui Yang, Jun-Xia Du, Hai-Jing Chen, Cai Qi, Zhi-Hua Huang, Ying Zhang, Yun Wang
JOURNAL OF NEUROSCIENCE
(2012)
Article
Neurosciences
Yan-Bing Zhu, Kai Kang, Ying Zhang, Cai Qi, Gang Li, Dong-Min Yin, Yun Wang
JOURNAL OF NEUROSCIENCE
(2012)
Article
Biochemistry & Molecular Biology
Yi Li, Ying Zhang, Ji-Sheng Han, Yun Wang
NEUROCHEMICAL RESEARCH
(2008)
Article
Neurosciences
Ning Wang, Ping Su, Ying Zhang, Jie Lu, Baoming Xing, Kai Kang, Wenqi Li, Yun Wang
NEUROPSYCHOPHARMACOLOGY
(2014)
Article
Anesthesiology
Haihao Zhu, Yanrui Yang, Hua Zhang, Yan Han, Yafang Li, Ying Zhang, Dongmin Yin, Qihua He, Zhiqi Zhao, Peter M. Blumberg, Jisheng Han, Yun Wang
Article
Biochemistry & Molecular Biology
Yi Li, Fang Hu, Hai-Jing Chen, Yi-Juan Du, Zhi-Ying Xie, Ying Zhang, Jun Wang, Yun Wang
Article
Multidisciplinary Sciences
Tianwen Huang, Shing-Hong Lin, Nathalie M. Malewicz, Yan Zhang, Ying Zhang, Martyn Goulding, Robert H. LaMotte, Qiufu Ma
Article
Neurosciences
Yu-Peng Guo, Yu-Ru Zhi, Ting-Ting Liu, Yun Wang, Ying Zhang
FRONTIERS IN MOLECULAR NEUROSCIENCE
(2019)
Article
Neurosciences
Yu-Ru Zhi, Feng Cao, Xiao-Jing Su, Shu-Wen Gao, Hao-Nan Zheng, Jin-Yan Jiang, Li Su, Jiao Liu, Yun Wang, Yan Zhang, Ying Zhang
Summary: This study reveals the crucial role of Cav3.2 in spinal SOM+ neurons in mechanosensation and mechanical allodynia. It provides a molecular basis for the transmission of mechanical pain by SOM+ neurons and demonstrates a functional role of Cav3.2 in tactile and pain processing at the level of spinal cord.
FRONTIERS IN CELLULAR NEUROSCIENCE
(2022)
Article
Neurosciences
Ying Wang, Wei-Yan Xie, Yi He, Min Wang, Yan-Rui Yang, Ying Zhang, Dong-Min Yin, Kelly L. Jordan-Sciutto, Ji-Sheng Han, Yun Wang
EXPERIMENTAL NEUROLOGY
(2006)